Life Sciences Week has ended
avatar for Mark Collins

Mark Collins

Vice President of Innovation and Strategy
Mark Collins is currently Vice President of Innovation and Strategy at Helomics where he is the chief architect of Helomics’ transition to an AI and data driven precision medicine company. Dr. Collins has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

My Speakers Sessions

Tuesday, May 14

4:00pm EDT


My Moderators Sessions

Tuesday, May 14

1:00pm EDT